Wilson Sonsini Goodrich & Rosati represented Gamebeast in the transaction. Gamebeast, a tooling platform in the user-generated content (UGC) video game industry “unlocking maximum growth potential”...
Gamebeast’s $3.7 Million Fundraise
Pie’s $11.5 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati represented Pie in the deal. Pie, a mobile events app, has raised $11.5 million in a Series A financing round. The...
Mangomint’s $35 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Mangomint on the transaction. Mangomint, the highest-rated salon and spa software provider, announced a $35 million Series B funding round...
Neurode’s $3.5 Million Pre-Seed Financing
Wilson Sonsini Goodrich & Rosati represented Neurode in the transaction. Neurode announced that it has raised $3.5 million in pre-Seed funding and is launching its private...
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
GreenLite’s $28.5 Million Series A Financing
Wilson Sonsini Goodrich and Rosati advised GreenLite on the transaction. GreenLite, a construction technology company making permitting faster and more predictable for builders, developers, and municipalities,...
Ripple Therapeutics’ License Agreement with AbbVie
Wilson Sonsini Goodrich & Rosati advised Ripple on the transaction. Ripple Therapeutics Corporation (Ripple) announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a...
Circle Pharma’s $90 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...
ONL Therapeutics’ $65 Million Series D Financing Round
Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters. ONL Therapeutics, Inc. announced...
Neo Medical SA’s Series B and $68 Million Equity Investment
Wilson Sonsini Goodrich & Rosati advised Neo Medical on U.S. aspects of the financing. Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery,...
Strider’s $55 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Strider Technologies, Inc. on the transaction. Strider Technologies, Inc., a leading provider of strategic intelligence, announced that it has closed...
SS&C Technologies’ $670 Million Acquisition of Battea-Class Action Services
Sidley Austin is representing Battea-Class Action Services in the transaction, and Davis Polk & Wardwell is representing SS&C Technologies Holdings, Inc. SS&C Technologies Holdings, Inc. (Nasdaq:...